| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antimicrobial Stewardship: A Creative Outlet for Clinicians
|
Scardina, Tonya
|
|
|
46 |
6 |
p. 442-443
|
artikel
|
| 2 |
Antiretroviral Stewardship: Top 10 Questions Encountered by Stewardship Teams and Solutions to Optimize Therapy
|
Chang, Mei H.
|
|
|
46 |
6 |
p. 455-462
|
artikel
|
| 3 |
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications
|
Hunter Hall, Rafe
|
|
|
46 |
6 |
p. e107-e113
|
artikel
|
| 4 |
Clinical Impact of Vancomycin MIC on Outcomes in Patients With Coagulase-negative Staphylococcal Bacteremia
|
Wheat, Wade
|
|
|
46 |
6 |
p. 444-450
|
artikel
|
| 5 |
Comparison of Cefazolin and Ceftriaxone Enterobacterales Susceptibilities for Inpatient Treatment of Urinary Tract Infections and Risk of Hospital-onset Clostridioides difficile Infection
|
Wombwell, Eric
|
|
|
46 |
6 |
p. 451-454
|
artikel
|
| 6 |
Comparison of Switching Between Antiretroviral Agents Versus Introducing Lipid-lowering Agents for HAART-induced Dyslipidemia
|
Mafumhe, Talent Farai
|
|
|
46 |
6 |
p. e114-e124
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
46 |
6 |
p. i-ii
|
artikel
|
| 8 |
Effectiveness of a Prostacyclin IP Receptor Agonist in Patients With Pulmonary Arterial Hypertension in the Real-world Andalusian Setting: The RAMPHA Study
|
Bravo-Marqués, Rafael
|
|
|
46 |
6 |
p. 509-514
|
artikel
|
| 9 |
Explainable and Interpretable Machine Learning for Antimicrobial Stewardship: Opportunities and Challenges
|
Giacobbe, Daniele Roberto
|
|
|
46 |
6 |
p. 474-480
|
artikel
|
| 10 |
Overview of the Participation of Nurses in Antimicrobial Stewardship Activities
|
Castro-Sánchez, Enrique
|
|
|
46 |
6 |
p. 469-473
|
artikel
|
| 11 |
Predicting Chronic Pain and Treatment Outcomes Using Machine Learning Models Based on High-dimensional Clinical Data From a Large Retrospective Cohort
|
Wu, Han
|
|
|
46 |
6 |
p. 490-498
|
artikel
|
| 12 |
Resmetirom
|
Beninger, Paul
|
|
|
46 |
6 |
p. 515-516
|
artikel
|
| 13 |
Risk of Enzyme- and Transporter-mediated Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2022: A Detailed Analysis of In Vitro and Clinical Data Available in New Drug Application Reviews
|
Yu, Jingjing
|
|
|
46 |
6 |
p. 499-508
|
artikel
|
| 14 |
The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy
|
Lee, Hae-Young
|
|
|
46 |
6 |
p. 481-489
|
artikel
|
| 15 |
The Importance of Ongoing Surveillance, Education, and Due Diligence for Antimicrobial Stewardship
|
Maron, Jill L.
|
|
|
46 |
6 |
p. 441
|
artikel
|
| 16 |
The Safety of Aztreonam Versus Ceftazidime in Patients Labeled With Penicillin Allergy: A Cohort Study
|
Tan, Jun Jie
|
|
|
46 |
6 |
p. 463-468
|
artikel
|
Tijdschrift beschrijving